Stay updated on Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    A Locations section now includes North Carolina (Durham, NC) for the study, replacing the former 'North Carolina Locations' entry. The HHS Vulnerability Disclosure link was removed from the footer, and the page revision updated from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T20:54:31.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    49 days ago
    Change Detected
    Summary
    The Publications note was updated to indicate that PubMed auto-filled publications may not be about the study, and the revision label was updated to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T11:01:01.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The funding/operating status notice was removed from the page.
    Difference
    0.4%
    Check dated 2025-11-18T07:00:26.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The study details page appears unchanged between versions; no new content or deletions are evident in the screenshots. The overall layout and information remain the same.
    Difference
    0.5%
    Check dated 2025-11-03T21:01:36.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    Updated operating-status notice and version 3.2.0; removed version 3.1.0.
    Difference
    2%
    Check dated 2025-10-06T05:30:48.000Z thumbnail image
  9. Check
    107 days ago
    Change Detected
    Summary
    Updated software version from v3.0.2 to v3.1.0; no other substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:04:15.000Z thumbnail image

Stay in the know with updates to Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial page.